메뉴 건너뛰기




Volumn 20, Issue , 2005, Pages 1274-

Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis [4]

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PR 39; RITUXIMAB;

EID: 20844449412     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh852     Document Type: Letter
Times cited : (19)

References (3)
  • 2
    • 0035674612 scopus 로고    scopus 로고
    • Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy
    • Specks U, Fervenza FC, McDonald TJ, Hogan MC. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 2001; 44: 2836-2840
    • (2001) Arthritis Rheum. , vol.44 , pp. 2836-2840
    • Specks, U.1    Fervenza, F.C.2    McDonald, T.J.3    Hogan, M.C.4
  • 3
    • 20844439802 scopus 로고    scopus 로고
    • Rituximab induced remission in a patient with Wegener's granulomatosis
    • Kallenbach M, Duan H, Ring T. Rituximab induced remission in a patient with Wegener's granulomatosis. Nephron Clin Pract 2005; 99: c92-c96
    • (2005) Nephron. Clin. Pract. , vol.99
    • Kallenbach, M.1    Duan, H.2    Ring, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.